99 Episoade

  1. Targeted therapy for BRAF-mutant pediatric glioma

    Publicat: 17.06.2022
  2. Early/evolving IDH wild-type glioblastoma

    Publicat: 20.05.2022
  3. PI3K signaling in IDH mutant gliomas

    Publicat: 06.05.2022
  4. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

    Publicat: 22.04.2022
  5. Molecular determinants of neurocognitive deficits in glioma

    Publicat: 08.04.2022
  6. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    Publicat: 25.03.2022
  7. Clinical trial accrual for women and minorities in neuro-oncology

    Publicat: 11.03.2022
  8. The clinical utility of next generation sequencing for IDHwt glioblastoma

    Publicat: 11.02.2022
  9. Trabectedin for recurrent grade 2 or 3 meningiomas

    Publicat: 28.01.2022
  10. Glioblastoma cell heterogeneity and plasticity

    Publicat: 14.01.2022
  11. Moleculary integrated grading for meningioma

    Publicat: 24.12.2021
  12. BOLD fMRI in IDH mutant gliomas

    Publicat: 10.12.2021
  13. Glioblastoma subtypes and response to Dasatinib

    Publicat: 26.11.2021
  14. Resection for recurrent brain metastases

    Publicat: 12.11.2021
  15. Incidental Meningiomas

    Publicat: 29.10.2021
  16. Immunosuppression in IDH mutant gliomas

    Publicat: 15.10.2021
  17. Immunotherapy for melanoma brain metastases

    Publicat: 01.10.2021
  18. DNA methylation profiles within the CATNON trial

    Publicat: 17.09.2021
  19. 18F FET PET in childhood CNS tumors

    Publicat: 03.09.2021
  20. Checkpoint blockade in atypical meningiomas

    Publicat: 20.08.2021

4 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site